The CEO of the Raleigh-Durham Airport Authority is anticipating an increase in summer leisure travel, disclosing today that American Airlines will offer a new nonstop flight from the RDU airport to Destin/Ft. Walton Beach, Florida, and new service to Orlando and Nashville beginning in early June.
Abzena, a global British contract development and manufacturing organization (CDMO), has announced a $213 million plan to join the fast-growing North Carolina biomanufacturing ecosystem.
“Capital is flowing well into venture,” says Clay Thorp, general partner at Hatteras Venture Partners, in an interview with WRAL TechWire, “especially into biotech/-ife science companies.” Here’s a look at what’s happening on the VC front.
Venture capital funds continue to raise funds at a blistering pace, as 141 funds garnered nearly $33 billion in the first quarter of 2021, which if the pace continues, means that 2021 could be the first year when fundraising surpasses $100 billion in total capital raised by the industry. But early-stage capital remains hard to get. Here’s advice on how to get it.
StrideBio, an emerging startup focusing on gene therapies which closed on a big $81.5 million round of venture capital in March, is partnering with Duke University as it expands efforts to create next-generation therapies.
Sponsored
For those adverse to the volatility and risk in the crypto sector, Coinbase says its direct listing will let investors buy into cryptocurrencies without having to own any individual digital currencies.
Sponsored
Polykemi, an international firm focused on “the best custom-designed plastic compounds in the world,” is coming to North Carolina.
Sponsored
Bioengineering startup Humacyte has secured $50 million in debt financing from Silicon Valley Bank as it prepares to go public through a SPAC merger with Alpha Healthcare Acquisition Corp.
Sponsored
NCSU researchers have found a way to fine-tune the molecular assembly line that creates antibiotics via engineered biosynthesis. The work could allow scientists to improve existing antibiotics as well as design new drug candidates quickly and efficiently.
Sponsored
“People with disabilities are problem solvers,” John Samuel says. “Every day, we have to figure out just how to get from point A to point B or to do some simple task. We persevere. We keep going. And that’s something that you can’t teach. What type of employer doesn’t want somebody like that?”
Sponsored
No one knows for sure what the post-coronavirus era holds. But businesses are doing their best to get ready, announcing a wave of mergers and takeover bids designed to prepare them for what’s next.
Sponsored
A recent case study from North Carolina State University and the University of North Carolina at Chapel Hill demonstrates that, with training, neural control of a powered prosthetic ankle can restore a wide range of abilities, including standing on very challenging surfaces and squatting.
Sponsored
A team led by scientists at the UNC School of Medicine identified a molecule called microRNA-29 as a powerful controller of brain maturation in mammals. Deleting microRNA-29 in mice caused problems very similar to those seen in autism, epilepsy, and other neurodevelopmental conditions.
Sponsored
The Federal Deposit Insurance Corporation (FDIC) and Duke University’s Pratt School of Engineering on Monday announced a strategic partnership to support technological innovation in the banking and financial services sectors.
Sponsored
Biotech firm Abzena is bringing more than 300 jobs to Sanford for a new biopharmaceutical manufacturing plant in an economic expansion announced Tuesday.
Sponsored
Southeast Asia’s ride-hailing giant Grab is setting the stage for an eye-popping Wall Street debut via a SPAC.
Sponsored
An investor group led by Caligan Partners LP that includes existing company directors Paul Manning and Roger Jeffs entered into a common stock purchase agreement with Liquidia Corporation (NASDAQ: LQDA) that will yield gross proceeds of approximately $21.7 million.
